spacer
home > ict > winter 2017 > up in the clouds
PUBLICATIONS
International Clinical Trials

Up in the Clouds

ICT: Compliance is, and will always be, a major challenge across the pharmaceutical and life sciences sector. In your opinion, what are the most pressing hurdles for healthcare businesses to adhere to global laws, industry codes and company policies?

Michaeline Daboul: The issue for organisations today is being able to quickly adapt to the evolving global laws that are impacting business activities while simultaneously containing expenditure and lowering the administrative burden on employees. The most pressing hurdles revolve around managing human workflows to reduce the risk of noncompliance with regards to industry laws that may result in costly investigations, litigation and expensive settlements. Ensuring compliance through business process improvement is one of the top challenges facing life science companies in 2017.

Furthermore, adherence to evolving laws, codes of conduct and global regulations are causing financial and administrative onuses. Current enterprise systems are not built to be flexible and adaptable to the changes required to comply with the aforementioned problems. In order to stay ahead, firms must not only address business processes, but also procedures that reduce cost as well as provide data that can be leveraged to manage risk and help to gain a competitive advantage.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Michaeline Daboul is the President and Chief Executive Officer of MMIS, whose team introduced MediSpend, the first SaaS compliance software solution for the life sciences industry. She has introduced disruptive technologies in the pharma sector for drug development, genomics research and compliance since 1985. Michaeline also mentors women in their technology careers and writes a blog for entrepreneurs and life science executives. She holds a degree in Biochemistry from Rutgers University, US.
spacer
Michaeline Daboul
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 – Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)


More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement